A Clinical Study to Evaluate the Efficacy and Safety of TQC2938 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

256

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

TQC2938 injection

TQC2938 is a humanized monoclonal antibody that interfering with the signal cascade.

DRUG

TQC2938 injection Placebo

TQC2938 is a humanized monoclonal antibody that interfering with the signal cascade.

Trial Locations (40)

20025

Shanghai JiaoTong University of medicine Ruijin Hospital, Shanghai

54000

Xingtai People's Hospital, Xingtai

100029

China-Japan Friendship Hospital, Beijing

100034

Peking University First Hospital, Beijing

135000

Meihekou Central Hospital, Meihekou

136099

Siping Central People's Hospital, Siping

154003

The First Affiliated Hospital of Jiamusi University, Jiamusi

161005

The First Hospital of Qiqihar, Qiqihar

200433

Shanghai Pulmonary Hospital, Shanghai

212050

Affiliated Hospital of Jiangsu University, Zhenjiang

230000

An Hui Chest Hospital, Hefei

261041

Weifang NO.2 People' Hospital, Weifang

300041

Tianjin Medical University General Hospital, Tianjin

300140

The Fourth Central Hospital of Tianjin, Tianjin

315211

The First Affiliated Hospitial Of Ningbo University, Ningbo

318000

Taizhou Hospital Of Zhejiang Province, Taizhou

321000

Jinhua Municipal Centeral Hospital Medical Group, Jinhua

325027

The 2th School of Medicine ,WMU/The 2th affiliated Hospital and Yuying Children's Hospital of WMU, Wenzhou

330000

Jiangxi Provincal People's Hospital, Nanchang

400054

Peolpe's Hospital Of Chongqing Banan District, Chongqing

410011

The second xiangya hospital of central south university, Changsha

422000

Shaoyang Central Hospital, Shaoyang

450000

Henan Chest Hospital, Zhengzhou

453000

The First People's Hospital of Xinxiang City, Xinxiang

457001

Puyang Oilfield General Hospital, Puyang

476600

Yongcheng People's Hospital, Yongcheng

528308

Shunde Hospital Of Southern Medical University, Foshan

529000

Jiangmen Central Hospital, Jiangmen

537000

The First People' Hospital Of YuLin, Yulin

545007

Liuzhou municipal liutie central hospital, Liuzhou

610081

Affiliated Hospital Of ChengDu University, Chengdu

614099

Leshan People's Hospital, Leshan

629000

Suining Central Hospital, Suining

710061

Xi'An International Medicl Center Hospital, Xi’an

830091

The Third People's Hospital of Xinjiang Uygur Autonomous Region, Ürümqi

061000

Cangzhou Central Hospital, Cangzhou

05000

The second hospital of hebei medical university, Shijiazhuang

010000

The Affiliated Hospital of Mongolia Medical College, Hohhot

Unknown

Heze Municipal Hospital, Heze

041099

Linfen Central Hospital, Linfen

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

INDUSTRY